Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatohepatitis (Phase 2 obesity study, 48-week data)
Editors note: Comments have been lightly edited for clarity and length
Those prioritizing family planning may benefit from discussing timing and alternative weight management strategies with their medical team
The participants on liraglutide had a 6.4% weight reduction
The largest decreases were seen in men and in people who reported joint or muscle pain
Peptide Sciences was running a pharmaceutical-scale operation under a research chemical disclaimer, and they did it for over a decade
US$ 27.31
US$ 29.09
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 25.73
US$ 20.09
